| Melissa Nicole Slone, RN | |
|
230 Vista Dr, Hazard, KY 41701-9449 | |
| (606) 438-5952 | |
| Not Available |
| Full Name | Melissa Nicole Slone |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 4 Years |
| Location | 230 Vista Dr, Hazard, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861009458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3015678 (Kentucky) | Primary |
| 163W00000X | Registered Nurse | 1131769 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hazard Arh Regional Medical Center | Hazard, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Triangle Anesthesia Group, Psc | 9436161585 | 68 |
News Archive
Ethiopia's new HIV/AIDS workplace policy, instituted in January by the government in cooperation with the country's main employees' and employers' associations, "is expected to protect job seekers from mandatory HIV tests, while facilitating voluntary counseling and testing and defending the right of employees living with HIV to medical leave or job re-allocation," PlusNews reports.
Hospitals all over the world must increase their efficiency and productivity and boost quality and safety, while containing and reducing costs.
ZymoGenetics, Inc. today announced positive survival data from a Phase 2a clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. Median overall survival was 12.4 months, and the percentage of patients surviving at 12 months was 53%.
A new study has found that there is a high level of meiotic recombination failure in human immature egg cells (oocytes).
› Verified 6 days ago
| Entity Name | Triangle Anesthesia Group, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124079314 PECOS PAC ID: 9436161585 Enrollment ID: O20060608000180 |
News Archive
Ethiopia's new HIV/AIDS workplace policy, instituted in January by the government in cooperation with the country's main employees' and employers' associations, "is expected to protect job seekers from mandatory HIV tests, while facilitating voluntary counseling and testing and defending the right of employees living with HIV to medical leave or job re-allocation," PlusNews reports.
Hospitals all over the world must increase their efficiency and productivity and boost quality and safety, while containing and reducing costs.
ZymoGenetics, Inc. today announced positive survival data from a Phase 2a clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. Median overall survival was 12.4 months, and the percentage of patients surviving at 12 months was 53%.
A new study has found that there is a high level of meiotic recombination failure in human immature egg cells (oocytes).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Nicole Slone, RN 230 Vista Dr, Hazard, KY 41701-9449 Ph: (606) 438-5952 | Melissa Nicole Slone, RN 230 Vista Dr, Hazard, KY 41701-9449 Ph: (606) 438-5952 |
News Archive
Ethiopia's new HIV/AIDS workplace policy, instituted in January by the government in cooperation with the country's main employees' and employers' associations, "is expected to protect job seekers from mandatory HIV tests, while facilitating voluntary counseling and testing and defending the right of employees living with HIV to medical leave or job re-allocation," PlusNews reports.
Hospitals all over the world must increase their efficiency and productivity and boost quality and safety, while containing and reducing costs.
ZymoGenetics, Inc. today announced positive survival data from a Phase 2a clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. Median overall survival was 12.4 months, and the percentage of patients surviving at 12 months was 53%.
A new study has found that there is a high level of meiotic recombination failure in human immature egg cells (oocytes).
› Verified 6 days ago
Kaitlyn E Shields, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 859-268-1030 Fax: 859-269-4120 | |
Brad S. Adams, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6600 | |
Mr. Michael A Shilot, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6600 | |
James B Lunsford, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6600 | |
Sarah Ratliff, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6600 | |
Kevin J Stanley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 859-268-1030 Fax: 859-269-4120 | |
Silas Shane Mcfall, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6600 |